Page last updated: 2024-10-24

limb morphogenesis

Definition

Target type: biologicalprocess

The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping. [UBERON:0002101]

Limb morphogenesis is a complex biological process involving the coordinated development of skeletal, muscular, vascular, and nervous structures to form functional limbs. This process begins during embryonic development and involves a series of precisely orchestrated events.

**1. Limb Bud Formation:**
- The first step is the formation of limb buds, which are small, bud-like structures that arise from the lateral plate mesoderm.
- These buds are induced by signals from the underlying somites and the apical ectodermal ridge (AER).
- The AER is a thickened region of ectoderm at the distal tip of the limb bud, and it plays a crucial role in limb outgrowth and patterning.

**2. Limb Outgrowth and Patterning:**
- The limb buds grow and elongate, driven by the proliferation of mesenchymal cells within the bud.
- The AER secretes signaling molecules, such as fibroblast growth factors (FGFs), which promote cell proliferation and maintain the growth zone of the limb bud.
- The zone of polarizing activity (ZPA), located at the posterior margin of the limb bud, secretes retinoic acid (RA) and sonic hedgehog (Shh) signaling molecules.
- These signals establish the anterior-posterior (A-P) axis of the limb and pattern the development of digits.

**3. Skeletal Development:**
- The mesenchymal cells within the limb bud differentiate into chondrocytes, which form the cartilage model of the skeleton.
- The cartilage model is subsequently replaced by bone through endochondral ossification.
- The pattern of skeletal elements, including the stylopod, zeugopod, and autopod, is determined by the interplay of signaling molecules from the AER and ZPA.

**4. Muscular Development:**
- Muscle precursor cells, known as myoblasts, migrate from the somites into the limb bud.
- Myoblasts fuse to form multinucleated myotubes, which differentiate into mature muscle fibers.
- The pattern of muscle development is influenced by signaling molecules from the AER and ZPA, as well as by interactions with the developing skeleton.

**5. Vascular Development:**
- Blood vessels develop within the limb bud, providing oxygen and nutrients for the growing tissues.
- Angiogenesis, the formation of new blood vessels, is regulated by signaling molecules from the AER, ZPA, and other tissues within the limb.

**6. Nervous Development:**
- Nerves also extend into the limb bud, providing innervation to the developing muscles and other tissues.
- Nerve growth factors (NGFs) and other guidance cues regulate the growth and pathfinding of axons.

**7. Limb Rotation:**
- In tetrapods, the limbs undergo a rotation during development, resulting in the characteristic orientation of the limbs in the body.
- The rotation is driven by changes in cell shape and the rearrangement of tissues within the limb bud.

**8. Limb Refinement:**
- The final stages of limb morphogenesis involve the refinement of the limb structures, including the shaping of the digits, the formation of joints, and the differentiation of specific muscle types.
- This process is regulated by a complex interplay of signaling molecules, transcription factors, and epigenetic modifications.

Limb morphogenesis is a highly regulated process that involves a complex interplay of signaling molecules, transcription factors, and cell-cell interactions. Disruptions in these processes can lead to birth defects affecting limb development.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Bcl-2 homologous antagonist/killerA Bcl-2 homologous antagonist/killer that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q16611]Homo sapiens (human)
Aspartyl/asparaginyl beta-hydroxylaseAn aspartyl/asparaginyl beta-hydroxylase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q12797]Homo sapiens (human)

Compounds (15)

CompoundDefinitionClassesRoles
gossypolGossypol: A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer.
2,4-pyridinedicarboxylic acidlutidinic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 4.pyridinedicarboxylic acid
alexidine dihydrchloride
6-n-tridecylsalicylic acid6-n-tridecylsalicylic acid: structure given in first sourcehydroxybenzoic acid
5,6-dehydrokawain5,6-dehydrokawain: from Alpinia speciosa rhizoma; RN given for cpd without isomeric designation; structure given in first source2-pyranones;
aromatic ether
bleomycinbleomycinantineoplastic agent;
metabolite
tubacintubacin: inhibits histone deacetylase 6; structure in first source1,3-oxazoles
belinostathydroxamic acid;
olefinic compound;
sulfonamide
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
midostaurinmidostaurin : An organic heterooctacyclic compound that is the N-benzoyl derivative of staurosporine.benzamides;
gamma-lactam;
indolocarbazole;
organic heterooctacyclic compound
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
navitoclaxaryl sulfide;
monochlorobenzenes;
morpholines;
N-sulfonylcarboxamide;
organofluorine compound;
piperazines;
secondary amino compound;
sulfone;
tertiary amino compound
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
plx4032aromatic ketone;
difluorobenzene;
monochlorobenzenes;
pyrrolopyridine;
sulfonamide
antineoplastic agent;
B-Raf inhibitor
meiogynin ameiogynin A: from the bark of Meiogyne cylindrocarpa; structure in first source
abt-199venetoclax : A member of the class of pyrrolopyridines that is a potent inhibitor of the antiapoptotic protein B-cell lymphoma 2. It is used for treamtment of chronic lymphocytic leukemia with 17p deletion.

venetoclax: A BCL-2 inhibitor with antineoplastic activity that is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA associated with chromosome 17p deletion; structure in first source.
aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
N-sulfonylcarboxamide;
oxanes;
pyrrolopyridine
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
jy-1-106JY-1-106: a BH3 alpha-helix mimetic that functions as a pan-Bcl-2 inhibitor; structure in first source